CEN Biotech Inc (CENBF)
0.0138
+0.01
(+176.00%)
USD |
OTCM |
Apr 19, 10:02
CEN Biotech Total Liabilities (Quarterly): 10.12M for March 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2023 | 10.12M |
| December 31, 2022 | 10.15M |
| September 30, 2022 | 10.02M |
| June 30, 2022 | 9.933M |
| March 31, 2022 | 10.24M |
| December 31, 2021 | 10.10M |
| September 30, 2021 | 11.48M |
| June 30, 2021 | 11.13M |
| March 31, 2021 | 16.68M |
| December 31, 2020 | 16.31M |
| September 30, 2020 | 35.90M |
| June 30, 2020 | 34.79M |
| March 31, 2020 | 33.76M |
| December 31, 2019 | 32.83M |
| September 30, 2019 | 31.97M |
| June 30, 2019 | 31.03M |
| Date | Value |
|---|---|
| March 31, 2019 | 29.81M |
| December 31, 2018 | 28.58M |
| September 30, 2018 | 27.41M |
| June 30, 2018 | 26.09M |
| March 31, 2018 | 25.16M |
| December 31, 2017 | 28.04M |
| September 30, 2017 | 21.48M |
| June 30, 2017 | 20.26M |
| March 31, 2017 | 19.25M |
| December 31, 2016 | 22.47M |
| September 30, 2016 | 16.42M |
| June 30, 2016 | 15.62M |
| March 31, 2016 | 14.68M |
| December 31, 2015 | 14.10M |
| September 30, 2015 | 13.51M |
| December 31, 2014 | 11.86M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
9.933M
Minimum
Jun 2022
35.90M
Maximum
Sep 2020
19.78M
Average
13.89M
Median
Total Liabilities (Quarterly) Benchmarks
| Rimrock Gold Corp | 0.4337M |
| InMed Pharmaceuticals Inc | 2.483M |
| Venus Concept Inc | 107.10M |
| Juva Life Inc | 11.45M |
| Lucy Scientific Discovery Inc | 4.206M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 7.447M |
| Shareholders Equity (Quarterly) | -2.672M |
| Debt to Equity Ratio | -1.847 |
| Current Ratio | 0.03 |
| Net Debt Paydown Yield | 4.48% |